FamiCord Group Central Laboratoryy with prestigous AABB accrediation

The Central Laboratory of the FamiCord Group has achieved prestigious AABB accreditation for Cellular Starting Material (CSM), underscoring FamiCord's commitment to upholding the highest standards of quality and safety, as well as continuous improvement of procedures related to the preparation of co...

More

Smart Cells International [Famicord Group] chooses Dubai as GCC hub for stem cell banking, expanding global presence

Dubai, Feb. 8, 2024— Smart Cells International (SCI), aleading member of FamiCord Group, proudly declares Dubai as its GCC hub for stem cell banking, solidifying its commitment to advancing healthcare solutions in the Middle East. SCI's decision to establish its state-of-the-art laboratory in Dubai...

More

Autologus cord blood in autism treatment- new clinical trial in Romania

Autologus cord blood in autism treatment- new clinical trial in Romania Researchers at Bioforum Foundation have been studying whether intravenous infusions of cord blood stem cells can help young children with autism spectrum disorder (ASD). The leader of this research group is dr Felician Stăncioi...

More

Cord blood transplant cures AIDS

In 1996, it was reported that 1% of the Caucasian race population is affected with mutation of CCR gene and that makes these individuals resistant to HIV infection, It was hypothesized that transplantation of hematopoietic stem cells from donors with this mutation to HIV positive patients would cu...

More